HC Wainwright & Co. Reiterates Buy on BiomX, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on BiomX (AMEX:PHGE) and maintained a $7 price target.
August 09, 2023 | 2:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BiomX's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $7.
The reiteration of the 'Buy' rating and maintenance of the $7 price target by HC Wainwright & Co. indicates their continued confidence in BiomX. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100